mMR
Showing 1 - 25 of 591
NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Non-small Cell Lung Cancer
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Jun 27, 2023
Tumor Vaccine Benefit for Gliomas
Recruiting
- Glioma
- DC vaccine
-
Shanghai, ChinaHuashan Hospital,Fudan University
Sep 12, 2023
Developing a MRI-based Deep Learning Model to Predict MMR Status
Not yet recruiting
- Endometrial Cancer
- randomly divided
- (no location specified)
Mar 13, 2023
IsThird Dose of MMRV Vaccine Beneficial for Adult Population in
Not yet recruiting
- Vaccination Failure
- Vaccine Response Impaired
- Serology for antibody levels - Baseline
- +3 more
- (no location specified)
Jun 26, 2023
Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
- +7 more
-
Brussels, Brussel, BelgiumUz Brussel
Sep 2, 2022
COVID-19 Trial in Goiânia (Influenza, MMR vaccines, Placebo)
Recruiting
- COVID-19
- Influenza
- +2 more
-
Goiânia, Goiás, BrazilFaculdade da Polícia Militar
May 27, 2022
Tumor Budding in Colorectal Cancer Under Different MMR Status
Completed
- Tumor Budding
- Rectal Cancer
- total mesorectal exicision
-
Guangzhou, Guangdong, ChinaDepartment of colorectal surgery, the Sixth Affiliated Hospital,
Nov 8, 2022
Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)
Recruiting
- Toripalimab
- Radiation
- Toripalimab
- +4 more
-
Hangzhou, Zhejiang, ChinaZhengjiang Cancer Hospital
Dec 29, 2022
Cancer, Coronary Artery Disease Trial in Los Angeles (PET-MR imaging on Biograph mMR scanner, MR-only imaging on Biograph mMR
Recruiting
- Cancer
- Coronary Artery Disease
- PET-MR imaging on Biograph mMR scanner
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 7, 2022
Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))
Not yet recruiting
- Mumps
- +2 more
- MMR booster vaccination (as M-M-R-VaxPro)
-
Zürich, SwitzerlandEpidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023
Chronic Disease Trial in Montpellier, Nîmes, Toulouse (Mutlidisciplinary medication Review (MMR), Mutlidisciplinary medication
Recruiting
- Chronic Disease
- Mutlidisciplinary medication Review (MMR)
- Mutlidisciplinary medication Review (MMR) with community pharmacist follow-up
-
Montpellier, France
- +2 more
Jan 6, 2023
Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))
Recruiting
- Colorectal Neoplasms
- Microsatellite Instability
- temozolomide (induction),
- pembrolizumab (treatment)
-
Milano, Italy
- +3 more
Sep 28, 2022
Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,
Not yet recruiting
- Pancreatic Cancer Metastatic
- Colorectal Cancer Metastatic
- Neoantigen Vaccine with Poly-ICLC adjuvant
- Retifanlimab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 5, 2022
Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi
Active, not recruiting
- Human Papilloma Virus Infection Type 16
- +4 more
- HPV+MMR(0d),HPV(6m)
- +2 more
-
Shaoxing, Zhejiang, China
- +1 more
Mar 14, 2022
Respiratory Tract Infections, Infections, Allergy Trial in Geneva (Measles-Mumps-Rubella vaccine (MMR))
Not yet recruiting
- Respiratory Tract Infections
- +3 more
- Measles-Mumps-Rubella vaccine (MMR)
-
Geneva, SwitzerlandUniversity Hospitals of Geneva
Feb 24, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
es to Capture the Real Life of Children With Rare Eye Diseases
Not yet recruiting
- Eye Diseases
- +3 more
- Mixed Methods Research (MMR) using quantitative (QUAN) and qualitative (QUAL) tools
-
Strasbourg, FranceCentre de Référence pour les Affections Rares en Génétique Ophta
Oct 3, 2023
Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients
Active, not recruiting
- Childhood Cancer
- Multiple Diseases
- Immunization Schedule patients <7 years.
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022
Biomarkers of Trained Immunity Following MMR Vaccination
Completed
- Covid19
- Heterologous stimuli
- Neutralization assay
-
Saint Louis, MissouriWashington University School of Medicine
Nov 24, 2021
Preventable Disease, Vaccine, Health Care Utilization Trial in Cincinnati (1 automated message, 2 automated messages, No
Completed
- Preventable Disease, Vaccine
- Health Care Utilization
- 1 automated message
- +3 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 12, 2021
Dengue, Dengue Hemorrhagic Fever, Yellow Fever Trial in Cali, Lima (Live, attenuated dengue serotype 1, 2, 3, and 4 virus,
Completed
- Dengue
- +2 more
- Live, attenuated dengue serotype 1, 2, 3, and 4 virus
- +8 more
-
Cali, Colombia
- +1 more
Mar 15, 2022
Ontogeny of Measles Immunity in Infants
Completed
- Measles
- Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous)
- MMR-II (Measles-Mumps-Rubella Virus Live Vaccine, 0.5ml subcutaneous)
-
Palo Alto, California
- +1 more
Jun 6, 2022